Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DVA
HALO
Add up to 3 more stocks
DVA
DaVita Inc.
+1.68%
$181.73+3.01Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$11.67B
52W Range
$101.00 - $247.49
HALO
Halozyme Therapeutics, Inc.
+1.20%
$109.61+1.30Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$13.00B
52W Range
$61.23 - $116.85
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 15.97 | 32.72 |
| Forward P/E | 12.30 | 13.03 |
| PEG Ratio | 1.93 | 1.42 |
| P/B Ratio | N/A | 90.57 |
| P/S Ratio | 0.83 | 7.81 |
| P/FCF Ratio | 7.25 | 16.13 |
| EV/EBITDA | 7.72 | 14.21 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 31.0% | 78.2% |
| Operating Margin | 15.1% | 56.8% |
| Net Margin | 6.0% | 24.9% |
| ROE | N/A | 288.1% |
| ROA | 4.8% | 16.1% |
| ROIC | 11.2% | 27.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.47 | 2.71 |
| Quick Ratio | 1.41 | 2.31 |
| Debt/Equity | N/A | 14.95 |
| Interest Coverage | 3.66 | 45.03 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.